Researchers have developed a novel injection-based therapy using smart hydrogels capable of sensing joint microenvironments and releasing regenerative factors, showing potential to reverse osteoarthritis joint damage.
Williams··2 min read
Japan has granted the world's first regulatory approval for the commercial sale of iPS cell-based medical treatments. This historic milestone, supported by extensive research in PubMed, transitions induced pluripotent stem cell technology from the laboratory to the clinic, positioning Japan as the global leader in regenerative medicine.
Jessy··3 min read
Japan has granted the world's first commercial approvals for medical products based on reprogrammed human cells (iPS cells), bringing a Nobel-winning discovery to the mass market. This regulatory milestone paves the way for advanced regenerative therapies for degenerative diseases. The decision highlights Japan's leadership in the field and is expected to accelerate global cell therapy adoption.
Williams··2 min read